Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Amino Acids ; 56(1): 3, 2024 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-38286913

RESUMO

Viral diseases are expected to cause new epidemics in the future, therefore, it is essential to assess how viral diversity is represented in terms of deposited protein structures. Here, data were collected from the Protein Data Bank to screen the available structures of viruses of interest to WHO. Excluding SARS-CoV-2 and HIV-1, less than 50 structures were found per year, indicating a lack of diversity. Efforts to determine viral structures are needed to increase preparedness for future public health challenges.


Assuntos
Proteínas , SARS-CoV-2 , Proteínas/química , Bases de Dados de Proteínas
2.
Nat Commun ; 12(1): 6844, 2021 11 25.
Artigo em Inglês | MEDLINE | ID: mdl-34824230

RESUMO

COVID-19 manifests as a milder disease in children than adults, but the underlying mechanisms are not fully characterized. Here we assess the difference in cellular or humoral immune responses of pediatric and adult COVID-19 patients to see if these factors contribute to the severity dichotomy. Children's non-specific immune profile is dominated by naive lymphocytes and HLA-DRhighCX3CR1low dendritic cells; meanwhile, children show strong specific antibody and T cell responses for viral structural proteins, with their T cell responses differing from adults by having weaker CD8+TNF+ T cells responses to S peptide pool but stronger responses to N and M peptide pools. Finally, viral mRNA is more abundant in pediatric patients. Our data thus support a scenario in which SARS-CoV-2 infected children contribute to transmission yet are less susceptible to COVID-19 symptoms due to strong and differential responses to the virus.


Assuntos
Anticorpos Antivirais/imunologia , COVID-19/imunologia , Imunidade Humoral , RNA Viral , SARS-CoV-2/genética , Vacinas Sintéticas/imunologia , Adolescente , Adulto , Idoso , Anticorpos Antivirais/sangue , Brasil , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Criança , Pré-Escolar , Citocinas/sangue , Feminino , Humanos , Imunidade Inata , Masculino , Pessoa de Meia-Idade , RNA Mensageiro , Glicoproteína da Espícula de Coronavírus/imunologia , Linfócitos T , Proteínas Estruturais Virais/imunologia , Adulto Jovem , Vacinas de mRNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA